Apple Vision Pro Is Now Being Used in Cataract Surgery

Apple Vision Pro has found a convincing professional use case: cataract surgery. Dr. Eric Rosenberg of SightMD in New York became the first surgeon to use the headset in an operating room, starting in October 2025. Since then, hundreds of procedures have been completed with the system — a scale that puts this well beyond a one-off experiment.

The setup

The key is a platform called ScopeXR, co-developed by Rosenberg himself. It streams a live 3D feed from a surgical microscope directly into the Vision Pro headset, replacing the eyepieces surgeons normally peer through. Diagnostic data and pre-operative calculations appear as overlays in the same view — so the surgeon never has to glance away at a separate monitor while manipulating the lens of a patient's eye, where precision is measured in fractions of a millimeter.

The October 2025 hardware update to Vision Pro — bringing in Apple's M5 chip — was what made this practical. Low latency and high pixel density are non-negotiable for microsurgery, and the M5 revision delivered both. ScopeXR connects to existing surgical hardware, including the Alcon Ngenuity 3D microscope, via standard HDMI, USB, or NDI connections.

The claim

Rosenberg frames the platform's biggest value as remote collaboration. A second surgeon anywhere in the world can join a procedure and see exactly what the operating surgeon sees, offering real-time guidance. The pitch is access: residents performing early procedures, or surgeons facing unexpected complications, could tap expert knowledge on demand.

> "We can now bring the world's best surgeon into any operating room, at any time of day, from anywhere on the planet." > — Dr. Eric Rosenberg

It's a compelling vision. But the clinical evidence is thin. No peer-reviewed study has compared patient outcomes under Vision Pro-assisted surgery against standard technique. Sharp HealthCare in San Diego is running the first IRB-approved prospective study, but detailed results — complication rates, operative time, visual acuity — have not been published. It's also worth noting that Rosenberg co-developed ScopeXR, so the volume claims and framing come with a vendor alignment caveat.

What comes next

At $3,499, Vision Pro is expensive for a consumer gadget but cheap compared to the specialized surgical visualization systems it could partially replace. Whether US hospitals adopt it at scale depends on what Sharp's study shows — and on FDA clearance pathways that haven't been publicly addressed yet. For now, this is a promising pilot, not an approved medical device.